In this podcast, I talked with Dr. Jimmy Li, CEO of WuXi XDC, a WuXi Biologics subsidiary. We discussed the reasons for the formation of WuXi XDC, which was established via a joint venture between WuXi Biologics and WuXi STA, a WuXi AppTec subsidiary, and how this company provides a true single-source for the discovery, development, and GMP manufacture of antibody drug conjugates and other novel bioconjugates with their highly efficient one-stop drug development platform.
Podden och tillhörande omslagsbild på den här sidan tillhör Brandy Sargent. Innehållet i podden är skapat av Brandy Sargent och inte av, eller tillsammans med, Poddtoppen.
